Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Other Working Capital Changes (2021 - 2024)

Goldenwell Biotech (GWLL) has disclosed Other Working Capital Changes for 4 consecutive years, with $54.0 as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Other Working Capital Changes changed N/A year-over-year to $54.0, compared with a TTM value of $54.0 through Mar 2025, down 88.0%, and an annual FY2023 reading of $504.0, down 64.26% over the prior year.
  • Other Working Capital Changes was $54.0 for Q2 2024 at Goldenwell Biotech, up from -$54.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $62586.0 in Q1 2021 and bottomed at -$71821.0 in Q4 2021.
  • Average Other Working Capital Changes over 4 years is $3018.0, with a median of -$3740.0 recorded in 2022.
  • The sharpest move saw Other Working Capital Changes surged 148.7% in 2022, then plummeted 578.4% in 2023.
  • Year by year, Other Working Capital Changes stood at -$71821.0 in 2021, then soared by 148.7% to $34976.0 in 2022, then fell by 26.02% to $25876.0 in 2023, then plummeted by 99.79% to $54.0 in 2024.
  • Business Quant data shows Other Working Capital Changes for GWLL at $54.0 in Q2 2024, -$54.0 in Q1 2024, and $25876.0 in Q4 2023.